Clinical Trials on Glioblastoma With Oligodendroglial Component in Korea, Democratic People's Republic of

Total 2 results

  • Novartis Pharmaceuticals
    Terminated
    Ceritinib Rare Indications Study in ALK+ Tumors
    Glioblastoma | Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumor | Tumors With Aberrations in ALK
    France, Czechia, Italy, Spain, Korea, Republic of, Thailand, Israel, Denmark
  • Forma Therapeutics, Inc.
    Completed
    A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation
    Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme) | Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) | Cohort 3a and 3b: Chondrosarcoma | Cohort 4a and 4b: Intrahepatic... and other conditions
    United States, Korea, Republic of, Australia, United Kingdom, Spain, France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe